UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
November 18, 2022 4:00 P.M.
Form:
S-3
CIK:
0001840233
Company Name:
Xilio Therapeutics, Inc.
File Number:
333-268264